Ask AI
ProCE Banner Series

Advances in Bladder Cancer Care: Expert Insights on Navigating Cutting-Edge Evidence and Evolving Treatment Strategies

Engage in this interactive live AUA chapter meeting as expert urologists discuss recent advances in bladder cancer care; address challenges in applying rapidly evolving evidence across non–muscle-invasive bladder cancer, muscle-invasive bladder cancer, and metastatic disease; and strategies to strengthen multidisciplinary collaboration.

  AMA
Who Should Attend

This activity has been designed to meet the educational needs of urologists, oncologists, and other healthcare professionals who care for patients with bladder cancer.

All Events

Advances in Bladder Cancer Care: Expert Insights on Navigating Cutting-Edge Evidence and Evolving Treatment Strategies

Upcoming Events

September

06

2025

12:30 PM - 1:30 PM Central Time (CT)

Virtual

Topics

Bladder cancer

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act 
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact customer support prior to the live event.

CME/CE Info

Goal Statement
This activity aims to improve learners’ knowledge and competence in managing patients with bladder cancer across the disease continuum. 

Target Audience
This activity has been designed to meet the educational needs of urologists, oncologists, and other healthcare professionals who care for patients with bladder cancer.

Learning Objectives
Upon completion of this event, participants should be able to:

  • Assess current and investigational strategies for the treatment of non-muscle-invasive bladder cancer and discuss with patients which approaches might benefit them
  • Implement optimal immunotherapy-based treatment for patients with muscle-invasive bladder cancer, focusing on recent data supporting bladder-sparing and perioperative approaches
  • Apply recent approvals and guideline-recommended strategies to improve outcomes in patients with metastatic bladder cancer in both the frontline and later-line settings
  • Assess available research findings and ongoing studies evaluating promising investigational agents and strategies for patients with non-muscle-invasive bladder cancer, muscle-invasive bladder cancer, and metastatic bladder cancer

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

Physician Continuing Medical Education

CCO designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

American Board of Internal Medicine Maintenance of Certification 

A blue and black sign with white textDescription automatically generated

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC point in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

For ABIM MOC points, your information will be shared with the ABIM through CCO's Joint Accreditation Program and Activity Reporting System (JAPARS). Please allow 6-8 weeks for your MOC points to appear on your ABIM records.

By sharing your Diplomate Board ID # and DOB, you are giving Clinical Care Options, LLC permission to use this information/data to report your participation to these Boards via the Joint Accreditation Program and Activity Reporting System (JA-PARS).

CME Passport

A logo for a companyDescription automatically generated

The CME credits that physicians earn from this activity will be submitted to ACCME's CME Passport, a free, centralized web application where you can create a personalized account to view, track, and generate transcripts of your reported CME credit. Visit www.cmepassport.org to create your account.

Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by

Provided by Clinical Care Options, LLC.

CCO 2022

Supporters

Supported by educational grants from AstraZeneca, Ferring Pharmaceuticals Inc., and Merck Sharp & Dohme LLC.

AstraZeneca

Ferring Pharmaceuticals Inc.

Merck Sharp & Dohme, LLC

For customer support please click here.

Mailing Address:

 

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 304
Reston, VA 20191